Tempol as a potential protective agent for nucleoside reverse transcriptase inhibitor (NRTI)-induced mitochondrial toxicity

被引:0
|
作者
Liu, Yongmin [1 ]
Liu, Yongmin [1 ]
Phuonggiang Nguyen [1 ]
Gibbons, Alexander [1 ]
Mitchell, James B. [2 ]
Poirier, Miriam C. [1 ]
机构
[1] NCI, Carcinogen DNA Interact Sect, NIH, Bethesda, MD 20892 USA
[2] NCI, LCBG & Tumor Biol Sect, RBB, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.mito.2012.07.021
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
22
引用
收藏
页码:557 / 558
页数:2
相关论文
共 50 条
  • [21] Prognostic factors for survival in nucleoside reverse transcriptase inhibitor(NRTI) induced lactic acidosis in a rural hospital in South Africa
    Krishnan, Sundar
    den Hollander, Daan
    Matos-Puig, Roel
    Naidu, Kevindra K.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A177 - A177
  • [22] Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity
    Krishna Kumar Ganta
    Anirban Mandal
    Binay Chaubey
    Cell Biology and Toxicology, 2017, 33 : 69 - 82
  • [23] Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity
    Ganta, Krishna Kumar
    Mandal, Anirban
    Chaubey, Binay
    CELL BIOLOGY AND TOXICOLOGY, 2017, 33 (01) : 69 - 82
  • [24] In Vitro Mitochondrial Toxicity of Metacavir, a New Nucleoside Reverse Transcriptase Inhibitor for Treatment of Hepatitis B Virus
    Zhang, Pinghu
    Zhang, Luyong
    Jiang, Zhenzhou
    Wang, Tao
    Chen, Hongkui
    Xiong, Yating
    Li, Zhan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) : 4887 - 4892
  • [25] Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors
    Pao, D
    Watson, C
    Peters, B
    Lucas, SB
    Miller, RF
    SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (05) : 381 - 384
  • [26] Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors
    Miller, RF
    Shahmanesh, M
    Hanna, MG
    Unwin, RJ
    Schapira, AHV
    Weller, IVD
    ANTIVIRAL THERAPY, 2003, 8 (03) : 253 - 257
  • [27] Nucleoside reverse transcriptase inhibitor resistance
    Loveday, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 : S10 - S24
  • [28] A high incidence of nucleoside reverse transcriptase inhibitor (NRTI)-induced lactic acidosis in HIV-infected patients in a South African context
    Geddes, Rosemary
    Knight, Stephen
    Moosa, Mahomed Yunus Suleman
    Reddi, Anand
    Uebel, Kerry
    Sunpath, Henry
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2006, 96 (08): : 722 - 724
  • [29] Nucleoside-reverse-transcriptase inhibitor associated mitochondrial toxicity in exposed HIV-infected pregnant women
    Kost, B.
    Sovric, M.
    Kaestner, R.
    Mylonas, I
    Friese, K.
    Gingelmaier, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (05) : 448 - 448
  • [30] Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity
    Divi, Rao L.
    Leonard, Sarah L.
    Kuo, Maryanne M.
    Nagashima, Kunio
    Thamire, Chandrasekhar
    St. Claire, Marisa C.
    Wade, Nancy A.
    Walker, Vernon E.
    Poirier, Miriam C.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2007, 48 (3-4) : 201 - 209